Altruist Bio
Hangzhou, China · altruistbio.com
GMP
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Altruist Biologics is a CDMO that provides development and GMP manufacturing services for biologics and bioconjugates, including antibodies, fusion proteins, recombinant proteins, and antibody drug conjugates. It serves customers developing and commercializing these products from early development through commercial supply, with facilities in Suzhou and Hangzhou, China.
Their website has a general contact form; we send your quote request through it.
What they offer
Mammalian Cell Line Development
Develops high-yield, stable mammalian cell lines and establishes primary, master, and working cell banks under GMP conditions.
Process Development
Provides cell culture process development, scale-up, process characterization, validation, and toxicology and clinical sample preparation.
Formulation Development
Develops robust formulations for drug substance and drug product, including container closure, in-use stability, and high-concentration formulation work.
Analytical Method Development
Develops, transfers, and validates analytical methods for CMC requirements, release testing, characterization, and stability studies.
GMP Drug Substance Manufacturing
Provides clinical- and commercial-scale GMP drug substance manufacturing for biologics.
GMP Drug Product Manufacturing
Provides clinical- and commercial-scale GMP drug product manufacturing.
Labeling & Packaging
Offers labeling and packaging services as part of manufacturing support.
ADC and Bioconjugation Development
Develops antibody drug conjugates and other bioconjugates, including payload, linker, and assembly work.
Regulatory Support
Provides integrated CMC and regulatory support for filings and commercialization activities.
What they work on
- Modalities
- Antibody, Bispecific, ADC, Recombinant protein
- Species and models
- mammalian cell culture, CHO-K1, CHO-S, CHO-K1 GS-KO
- Assays and studies
- bioassays, binding ELISA, peptide mapping, CE-SDS, SEC, icIEF, CEX, residual DNA testing, HCP testing, Protein A testing, comparability testing, stability testing
- Instruments and platforms
- Ambr 250, ÄKTA pure, ÄKTA avant, ÄKTA pcc, Beckman Biomek i5 workstation, ÄKTA process, ÄKTA ready, Tecan, LabChip
- Scale and capacity
- 50 L to 500 L non-GMP pilot scales, 1 kL to 20 kL, 1,000 L to 20,000 L, 4 x 20,000 L stainless steel bioreactors, 232,000 liters expected total capacity by 2026
- Therapeutic areas
- cancer, cardiovascular disease, metabolic disease, autoimmune disease, eye disease
- Turnaround
- 10 weeks from DNA to Primary Cell Bank generation · Six or more months to evaluate final formulation
- Type
- CDMO
- Sites
- Suzhou, China · Hangzhou, China
- Team
- 1.2K+ Highly Skilled Employees
- Quality
- GMP (drug substance manufacturing, drug product manufacturing, clinical and commercial production) · cGMP (analytical testing and quality control) · ICH guidelines (method qualification and validation) · FDA, EMA, PMDA, and NMPA (passed inspections from multiple global regulatory agencies)
- Serves
- global
- Founded
- 2022
Similar labs. Avid Bioservices, Kemwell Pharma, Intellective Bio, ORF Biologics
Found in a contract services directory. Listing built from altruistbio.com. Work here? Claim this listing.